Market Overview:
The global minimally invasive female urinary incontinence devices market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of female urinary incontinence, technological advancements in minimally invasive devices, and rising demand for minimally invasive procedures. The global minimally invasive female urinary incontinence devices market by type is segmented into external urinary incontinence devices and internal urinary incontinence devices. The internal urinary incontinence devices segment is further sub-segmented into transurethral slings, mid-urethral slings, injectable bulking agents, and others (including urethral plugs and artificial sphincters). The external urinary incontinent device segment is further sub-segmented into pessaries, vaginal cones/balls/discs, and others (including urethral covers/shields). The global minimally invasive female Urinary Incontinence Devices Market by application is segmented into ambulatory surgical centers (ASC), gynecology clinics, hospitals & other healthcare settings), and region wise North America , Latin America , Europe Asia Pacific & Middle East Africa .
Product Definition:
Minimally invasive female urinary incontinence devices are medical devices that treat or prevent urinary incontinence in women. These devices include slings, meshes, and other implantable materials that are inserted through small incisions in the body. Minimally invasive female urinary incontinence devices offer a number of benefits over traditional surgical procedures, including smaller scars, less pain and discomfort, and a shorter recovery time.
External Urinary Incontinence Devices:
External urinary incontinence devices, also called as urological pads or continent urinals are used for the treatment of stress and urge incontinence. These devices are placed in the patient’s undergarments or outerwear to collect urine. The collection device is connected by a drainage hose to a urine collection bottle or can be directly attached to the toilet.
Internal Urinary Incontinence Devices:
Internal urinary incontinence devices and it's usage in minimally invasive female urinary incontinence devices market is expected to grow at a lucrative rate during the forecast period.
Application Insights:
The global market is segmented by application into ambulatory surgical centers, gynecology clinics, and hospitals. The hospital segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as a high prevalence of female urinary incontinence and increasing awareness about the availability of advanced products for treating this condition among patients undergoing diagnostic procedures at hospitals or other medical institutions.
External ureteroscopy has been found to be more effective than open surgery for diagnosing refluxing urine or retrograde flow after cystoscopic removal of kidney stones.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, high disposable income, and rising awareness about urinary incontinence treatment options. In addition, increasing demand for minimally invasive surgeries due to growing geriatric population is expected to drive growth over the forecast period. Europe accounted for a significant share in terms of revenue as well as volume in 2017 owing to growing demand from countries such as Germany and France.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing its large geriatric population base coupled with rapidly improving healthcare infrastructure.
Growth Factors:
- Increasing incidence of urinary incontinence in females
- Rising awareness about minimally invasive female urinary incontinence devices
- Technological advancements in the field of minimally invasive female urinary incontinence devices
- Growing demand for minimally invasive female urinary incontinence devices from emerging markets
- increasing number of product launches and approvals by regulatory authorities
Scope Of The Report
Report Attributes
Report Details
Report Title
Minimally Invasive Female Urinary Incontinence Devices Market Research Report
By Type
External Urinary Incontinence Devices, Internal Urinary Incontinence Devices
By Application
Ambulatory Surgical Centers, Gynecology Clinics, Hospitals
By Companies
Axonics Modulation Technologies, Inc, Bioness, Inc., BlueWind Medical Ltd., Boston Scientific Corporation, Caldera Medical, Inc., Carbon Medical Technologies, Inc., CL Medical, Cogentix Medical, Coloplast Corporation, Cousin Biotech, C. R. Bard, Inc. (Becton, Dickinson and Company), Ethicon, Inc./Johnson & Johnson, FemPulse, LLC, InterStim, Medtronic, Inc., Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA, NURO Sys, Nuvectra Corporation, StimGuard LLC.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
157
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Minimally Invasive Female Urinary Incontinence Devices Market Report Segments:
The global Minimally Invasive Female Urinary Incontinence Devices market is segmented on the basis of:
Types
External Urinary Incontinence Devices, Internal Urinary Incontinence Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ambulatory Surgical Centers, Gynecology Clinics, Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Axonics Modulation Technologies, Inc
- Bioness, Inc.
- BlueWind Medical Ltd.
- Boston Scientific Corporation
- Caldera Medical, Inc.
- Carbon Medical Technologies, Inc.
- CL Medical
- Cogentix Medical, Coloplast Corporation, Cousin Biotech
- C. R. Bard, Inc. (Becton, Dickinson and Company)
- Ethicon, Inc./Johnson & Johnson
- FemPulse, LLC
- InterStim, Medtronic, Inc.
- Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA
- NURO Sys
- Nuvectra Corporation
- StimGuard LLC.
Highlights of The Minimally Invasive Female Urinary Incontinence Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- External Urinary Incontinence Devices
- Internal Urinary Incontinence Devices
- By Application:
- Ambulatory Surgical Centers
- Gynecology Clinics
- Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Minimally Invasive Female Urinary Incontinence Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Minimally invasive female urinary incontinence devices (MIFUDs) are a type of medical device that help women with urinary incontinence. MIFUDs are inserted into the bladder through the urethra, and they help to improve continence by providing support for the pelvic floor muscles.
Some of the key players operating in the minimally invasive female urinary incontinence devices market are Axonics Modulation Technologies, Inc, Bioness, Inc., BlueWind Medical Ltd., Boston Scientific Corporation, Caldera Medical, Inc., Carbon Medical Technologies, Inc., CL Medical, Cogentix Medical, Coloplast Corporation, Cousin Biotech, C. R. Bard, Inc. (Becton, Dickinson and Company), Ethicon, Inc./Johnson & Johnson, FemPulse, LLC, InterStim, Medtronic, Inc., Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA, NURO Sys, Nuvectra Corporation, StimGuard LLC..
The minimally invasive female urinary incontinence devices market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Minimally Invasive Female Urinary Incontinence Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Minimally Invasive Female Urinary Incontinence Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Minimally Invasive Female Urinary Incontinence Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Minimally Invasive Female Urinary Incontinence Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Minimally Invasive Female Urinary Incontinence Devices Market Size & Forecast, 2018-2028
4.5.1 Minimally Invasive Female Urinary Incontinence Devices Market Size and Y-o-Y Growth
4.5.2 Minimally Invasive Female Urinary Incontinence Devices Market Absolute $ Opportunity
Chapter 5 Global Minimally Invasive Female Urinary Incontinence Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Type
5.2.1 External Urinary Incontinence Devices
5.2.2 Internal Urinary Incontinence Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Minimally Invasive Female Urinary Incontinence Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Applications
6.2.1 Ambulatory Surgical Centers
6.2.2 Gynecology Clinics
6.2.3 Hospitals
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Minimally Invasive Female Urinary Incontinence Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Minimally Invasive Female Urinary Incontinence Devices Analysis and Forecast
9.1 Introduction
9.2 North America Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Type
9.6.1 External Urinary Incontinence Devices
9.6.2 Internal Urinary Incontinence Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Applications
9.10.1 Ambulatory Surgical Centers
9.10.2 Gynecology Clinics
9.10.3 Hospitals
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Minimally Invasive Female Urinary Incontinence Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Type
10.6.1 External Urinary Incontinence Devices
10.6.2 Internal Urinary Incontinence Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Applications
10.10.1 Ambulatory Surgical Centers
10.10.2 Gynecology Clinics
10.10.3 Hospitals
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Minimally Invasive Female Urinary Incontinence Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Type
11.6.1 External Urinary Incontinence Devices
11.6.2 Internal Urinary Incontinence Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Applications
11.10.1 Ambulatory Surgical Centers
11.10.2 Gynecology Clinics
11.10.3 Hospitals
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Minimally Invasive Female Urinary Incontinence Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Type
12.6.1 External Urinary Incontinence Devices
12.6.2 Internal Urinary Incontinence Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Applications
12.10.1 Ambulatory Surgical Centers
12.10.2 Gynecology Clinics
12.10.3 Hospitals
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Minimally Invasive Female Urinary Incontinence Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Type
13.6.1 External Urinary Incontinence Devices
13.6.2 Internal Urinary Incontinence Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Applications
13.10.1 Ambulatory Surgical Centers
13.10.2 Gynecology Clinics
13.10.3 Hospitals
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Minimally Invasive Female Urinary Incontinence Devices Market: Competitive Dashboard
14.2 Global Minimally Invasive Female Urinary Incontinence Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Axonics Modulation Technologies, Inc
14.3.2 Bioness, Inc.
14.3.3 BlueWind Medical Ltd.
14.3.4 Boston Scientific Corporation
14.3.5 Caldera Medical, Inc.
14.3.6 Carbon Medical Technologies, Inc.
14.3.7 CL Medical
14.3.8 Cogentix Medical, Coloplast Corporation, Cousin Biotech
14.3.9 C. R. Bard, Inc. (Becton, Dickinson and Company)
14.3.10 Ethicon, Inc./Johnson & Johnson
14.3.11 FemPulse, LLC
14.3.12 InterStim, Medtronic, Inc.
14.3.13 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA
14.3.14 NURO Sys
14.3.15 Nuvectra Corporation
14.3.16 StimGuard LLC.
